Risk and Outcome of Infective Endocarditis in Streptococcal Bloodstream Infections according to Streptococcal Species.
Streptococcus
bacteremia
echocardiography
infective endocarditis
mortality
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
17 08 2023
17 08 2023
Historique:
medline:
21
8
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
ppublish
Résumé
This study aimed to identify which streptococcal species are closely associated with infective endocarditis (IE) and to evaluate risk factors for mortality in patients with streptococcal IE. We performed a retrospective cohort study of all patients with streptococcal bloodstream infection (BSI) from January 2010 to June 2020 in a tertiary hospital in South Korea. We compared clinical and microbiological characteristics of streptococcal BSIs according to the diagnosis of IE. We performed multivariate analysis to evaluate the risk of IE according to streptococcal species and risk factors for mortality in streptococcal IE. A total of 2,737 patients were identified during the study period, and 174 (6.4%) were diagnosed with IE. The highest IE prevalence was in patients with Streptococcus mutans BSI (33% [9/27]) followed by S. sanguinis (31% [20/64]), S. gordonii (23% [5/22]), S. gallolyticus (16% [12/77]), and S. oralis (12% [14/115]). In multivariate analysis, previous IE, high-grade BSI, native valve disease, prosthetic valve, congenital heart disease, and community-onset BSI were independent risk factors for IE. After adjusting for these factors, S. sanguinis (adjusted OR [aOR], 7.75), S. mutans (aOR, 5.50), and S. gallolyticus (aOR, 2.57) were significantly associated with higher risk of IE, whereas S. pneumoniae (aOR, 0.23) and
Identifiants
pubmed: 37284757
doi: 10.1128/spectrum.01049-23
pmc: PMC10434186
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0104923Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
BMC Cardiovasc Disord. 2021 Jan 12;21(1):28
pubmed: 33435885
Scand J Infect Dis. 1995;27(1):19-21
pubmed: 7784808
Circulation. 2020 Aug 25;142(8):720-730
pubmed: 32580572
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
J Korean Med Sci. 2014 Jun;29(6):776-81
pubmed: 24932077
N Engl J Med. 2012 Jun 28;366(26):2466-73
pubmed: 22738096
Circulation. 2015 Oct 13;132(15):1435-86
pubmed: 26373316
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
BMC Med. 2014 Mar 06;12:40
pubmed: 24597462
Heart. 2021 Jan;107(2):135-141
pubmed: 33033067
J Clin Microbiol. 2008 Sep;46(9):3087-90
pubmed: 18650347
Clin Infect Dis. 2018 Feb 10;66(5):693-698
pubmed: 29040411
Diagn Microbiol Infect Dis. 2018 Jul;91(3):269-272
pubmed: 29567126
J Am Coll Cardiol. 2017 Dec 5;70(22):2795-2804
pubmed: 29191329
Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):215-8
pubmed: 26610338
Int J Med Microbiol. 2014 May;304(3-4):262-8
pubmed: 24220665
PLoS One. 2019 Oct 25;14(10):e0223857
pubmed: 31652280
J Am Coll Cardiol. 2019 Jul 16;74(2):193-201
pubmed: 31296291
Clin Microbiol Rev. 2002 Oct;15(4):613-30
pubmed: 12364372
Heart. 2000 Jul;84(1):25-30
pubmed: 10862581
Rev Infect Dis. 1979 Nov-Dec;1(6):955-66
pubmed: 551516